1. Home
  2. ADVM vs BAER Comparison

ADVM vs BAER Comparison

Compare ADVM & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • BAER
  • Stock Information
  • Founded
  • ADVM 2006
  • BAER 2014
  • Country
  • ADVM United States
  • BAER United States
  • Employees
  • ADVM N/A
  • BAER N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • BAER Blank Checks
  • Sector
  • ADVM Health Care
  • BAER Finance
  • Exchange
  • ADVM Nasdaq
  • BAER Nasdaq
  • Market Cap
  • ADVM 140.6M
  • BAER 154.7M
  • IPO Year
  • ADVM 2014
  • BAER N/A
  • Fundamental
  • Price
  • ADVM $7.30
  • BAER $2.62
  • Analyst Decision
  • ADVM Strong Buy
  • BAER Strong Buy
  • Analyst Count
  • ADVM 6
  • BAER 1
  • Target Price
  • ADVM $28.17
  • BAER $5.25
  • AVG Volume (30 Days)
  • ADVM 144.8K
  • BAER 175.8K
  • Earning Date
  • ADVM 11-07-2024
  • BAER 11-11-2024
  • Dividend Yield
  • ADVM N/A
  • BAER N/A
  • EPS Growth
  • ADVM N/A
  • BAER N/A
  • EPS
  • ADVM N/A
  • BAER N/A
  • Revenue
  • ADVM N/A
  • BAER $73,248,000.00
  • Revenue This Year
  • ADVM N/A
  • BAER $26.61
  • Revenue Next Year
  • ADVM $5,848.83
  • BAER N/A
  • P/E Ratio
  • ADVM N/A
  • BAER N/A
  • Revenue Growth
  • ADVM N/A
  • BAER 60.82
  • 52 Week Low
  • ADVM $6.38
  • BAER $1.71
  • 52 Week High
  • ADVM $29.70
  • BAER $9.19
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 55.10
  • BAER 47.20
  • Support Level
  • ADVM $6.54
  • BAER $2.40
  • Resistance Level
  • ADVM $7.20
  • BAER $2.98
  • Average True Range (ATR)
  • ADVM 0.35
  • BAER 0.42
  • MACD
  • ADVM 0.06
  • BAER 0.04
  • Stochastic Oscillator
  • ADVM 67.26
  • BAER 67.91

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF ("Super Scooper") aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.

Share on Social Networks: